VIA
Vident Investment Advisory’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,008
| Closed | -$325K | – | 1297 |
|
|
2023
Q1 | $325K | Buy |
+14,008
| New | +$325K | 0.01% | 925 |
|
|
2022
Q1 | – | Sell |
-7,374
| Closed | -$204K | – | 1323 |
|
|
2021
Q4 | $204K | Buy |
+7,374
| New | +$204K | 0.01% | 1130 |
|
|
2021
Q3 | – | Sell |
-6,689
| Closed | -$205K | – | 1204 |
|
|
2021
Q2 | $205K | Buy |
+6,689
| New | +$205K | 0.01% | 1051 |
|
|
2018
Q3 | – | Sell |
-86,231
| Closed | -$3.22M | – | 977 |
|
|
2018
Q2 | $3.22M | Buy |
86,231
+1,293
| +2% | +$48.3K | 0.13% | 212 |
|
|
2018
Q1 | $2.46M | Sell |
84,938
-30,183
| -26% | -$876K | 0.1% | 283 |
|
|
2017
Q4 | $3.95M | Buy |
115,121
+7,029
| +7% | +$241K | 0.18% | 101 |
|
|
2017
Q3 | $3.91M | Sell |
108,092
-46,975
| -30% | -$1.7M | 0.21% | 81 |
|
|
2017
Q2 | $4.01M | Buy |
155,067
+2,641
| +2% | +$68.2K | 0.33% | 65 |
|
|
2017
Q1 | $2.93M | Buy |
+152,426
| New | +$2.93M | 0.29% | 80 |
|
|
2016
Q3 | – | Sell |
-50,802
| Closed | -$1.56M | – | 441 |
|
|
2016
Q2 | $1.56M | Sell |
50,802
-49,080
| -49% | -$1.5M | 0.22% | 242 |
|
|
2016
Q1 | $3.74K | Buy |
99,882
+51,065
| +105% | +$1.91K | 0.23% | 221 |
|
|
2015
Q4 | $2.11M | Buy |
48,817
+29,128
| +148% | +$1.26M | 0.27% | 169 |
|
|
2015
Q3 | $738K | Buy |
19,689
+2,908
| +17% | +$109K | 0.1% | 307 |
|
|
2015
Q2 | $570K | Buy |
16,781
+908
| +6% | +$30.8K | 0.08% | 416 |
|
|
2015
Q1 | $562K | Buy |
15,873
+1,826
| +13% | +$64.7K | 0.11% | 334 |
|
|
2014
Q4 | $478K | Buy |
+14,047
| New | +$478K | 0.16% | 265 |
|